EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy

Yee Jie Yeap iD, Tng J W Teddy iD, Mok Jung Lee iD, Micaela Goh, Kah Leong Lim iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032523 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yee Jie Yeap und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Parkinson Disease, Pluripotent Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Singapore Ministry of Health, Singapore National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s Disease (PD) is a prevalent neurodegenerative disorder that is characterized pathologically by the loss of A9-specific dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Despite intensive research, the etiology of PD is currently unresolved, and the disease remains incurable. This, in part, is due to the lack of an experimental disease model that could faithfully recapitulate the features of human PD. However, the recent advent of induced pluripotent stem cell (iPSC) technology has allowed PD models to be created from patient-derived cells. Indeed, DA neurons from PD patients are now routinely established in many laboratories as monolayers as well as 3D organoid cultures that serve as useful toolboxes for understanding the mechanism underlying PD and also for drug discovery. At the same time, the iPSC technology also provides unprecedented opportunity for autologous cell-based therapy for the PD patient to be performed using the patient’s own cells as starting materials. In this review, we provide an update on the molecular processes underpinning the development and differentiation of human pluripotent stem cells (PSCs) into midbrain DA neurons in both 2D and 3D cultures, as well as the latest advancements in using these cells for drug discovery and regenerative medicine. For the novice entering the field, the cornucopia of differentiation protocols reported for the generation of midbrain DA neurons may seem daunting. Here, we have distilled the essence of the different approaches and summarized the main factors driving DA neuronal differentiation, with the view to provide a useful guide to newcomers who are interested in developing iPSC-based models of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePluripotent Stem CellsInduced Pluripotent Stem CellsHumansMesencephalonDopaminergic NeuronsOrganoids

Stichwörter der Autor:innen

Parkinson’s Diseaseallogeneic transplantationclinical trialdopaminergic neuronsmesencephalonmicrofluidicmidbrainorganoidspluripotent stem cellsregenerative medicine

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
  • Interdisciplinary Graduate Programme (IGP-Neuroscience), Nanyang Technological University, Singapore 639798, Singapore.
  • National Neuroscience Institute, Singapore 308433, Singapore.
  • Department of Brain Sciences, Imperial College London, London SW7 2AZ, UK.
  • Department of Anatomy, Shanxi Medical University, Taiyuan 030001, China.

ORCID-Profile: Yee Jie Yeap, Tng J W Teddy, Mok Jung Lee, Kah Leong Lim

Förderung

  • National Research Foundation
  • Singapore Ministry of Health
  • Singapore National Research Foundation

Zitieren

APA

Yeap, Y. J., Teddy, T. J. W., Lee, M. J., Goh, M., & Lim, K. L. (2023). From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032523

Vancouver

Yeap YJ, Teddy TJW, Lee MJ, Goh M, Lim KL. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032523

BibTeX
@article{Yeap2023,
  author = {Yeap, Yee Jie and Teddy, Tng J W and Lee, Mok Jung and Goh, Micaela and Lim, Kah Leong},
  title = {From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032523}
}
Kostenlos starten →